US · AAPG
Ascentage Pharma Group International
Programmatic access: InvestorsCraft Valuation API · catalog
Price · as of 2026-09-04
$17.61
Market cap 1.57B
Price history
| Week | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jan 20, 2025 – Jan 24, 2025 | $17.25 | $18.00 | $16.50 | $17.38 | |
| Jan 27, 2025 – Jan 31, 2025 | $17.39 | $17.97 | $17.00 | $17.68 | 0 |
| Feb 3, 2025 – Feb 7, 2025 | $17.80 | $19.37 | $17.80 | $18.67 | 0 |
| Feb 10, 2025 – Feb 14, 2025 | $18.70 | $18.99 | $17.09 | $18.24 | 0 |
| Feb 17, 2025 – Feb 21, 2025 | $18.55 | $21.40 | $18.35 | $21.17 | 0 |
| Feb 24, 2025 – Feb 28, 2025 | $21.09 | $21.09 | $18.45 | $19.03 | 0 |
| Mar 3, 2025 – Mar 7, 2025 | $19.51 | $19.93 | $18.30 | $19.93 | 0 |
| Mar 10, 2025 – Mar 14, 2025 | $19.57 | $19.57 | $18.42 | $19.00 | 0 |
| Mar 17, 2025 – Mar 21, 2025 | $18.86 | $19.86 | $18.60 | $18.70 | 0 |
| Mar 24, 2025 – Mar 28, 2025 | $18.79 | $22.43 | $18.18 | $21.65 | 0 |
| Mar 31, 2025 – Apr 4, 2025 | $20.75 | $24.02 | $19.63 | $20.95 | 0 |
| Apr 7, 2025 – Apr 11, 2025 | $18.41 | $21.20 | $17.56 | $18.70 | 0 |
| Apr 14, 2025 – Apr 17, 2025 | $19.33 | $20.88 | $18.52 | $18.72 | 0 |
| Apr 21, 2025 – Apr 25, 2025 | $19.14 | $26.50 | $18.87 | $26.30 | 0 |
| Apr 28, 2025 – May 2, 2025 | $25.65 | $26.00 | $24.09 | $25.48 | 0 |
| May 5, 2025 – May 9, 2025 | $25.50 | $26.00 | $23.67 | $24.31 | 0 |
| May 12, 2025 – May 16, 2025 | $23.88 | $24.69 | $22.56 | $22.65 | 0 |
| May 19, 2025 – May 23, 2025 | $22.89 | $26.55 | $22.89 | $26.48 | 0 |
| May 26, 2025 – May 30, 2025 | $25.88 | $26.06 | $23.06 | $24.40 | 0 |
| Jun 2, 2025 – Jun 6, 2025 | $24.60 | $28.68 | $24.56 | $28.38 | 0 |
| Jun 9, 2025 – Jun 13, 2025 | $29.16 | $32.15 | $29.15 | $31.51 | 0 |
| Jun 16, 2025 – Jun 20, 2025 | $32.12 | $37.95 | $31.08 | $37.38 | 0 |
| Jun 23, 2025 – Jun 27, 2025 | $37.36 | $40.81 | $35.98 | $39.60 | 0 |
| Jun 30, 2025 – Jul 3, 2025 | $38.83 | $43.58 | $38.44 | $42.85 | 0 |
| Jul 7, 2025 – Jul 11, 2025 | $42.00 | $42.94 | $38.15 | $38.24 | 0 |
| Jul 14, 2025 – Jul 18, 2025 | $37.05 | $41.38 | $36.08 | $40.39 | 0 |
| Jul 21, 2025 – Jul 25, 2025 | $40.18 | $40.39 | $37.76 | $37.80 | 0 |
| Jul 28, 2025 – Aug 1, 2025 | $39.79 | $40.17 | $36.00 | $37.20 | 0 |
| Aug 4, 2025 – Aug 8, 2025 | $37.60 | $43.41 | $37.30 | $41.95 | 0 |
| Aug 11, 2025 – Aug 15, 2025 | $39.82 | $45.40 | $39.61 | $45.00 | 0 |
| Aug 18, 2025 – Aug 22, 2025 | $46.99 | $48.45 | $45.90 | $47.90 | 0 |
| Aug 25, 2025 – Aug 29, 2025 | $45.90 | $45.90 | $41.01 | $42.47 | 0 |
| Sep 1, 2025 – Sep 5, 2025 | $41.95 | $42.47 | $38.00 | $40.50 | 0 |
| Sep 8, 2025 – Sep 12, 2025 | $41.20 | $41.40 | $38.39 | $40.46 | 0 |
| Sep 15, 2025 – Sep 19, 2025 | $39.98 | $39.98 | $37.99 | $38.85 | 0 |
| Sep 22, 2025 – Sep 26, 2025 | $38.65 | $38.93 | $37.15 | $37.33 | 0 |
| Sep 29, 2025 – Oct 3, 2025 | $38.38 | $40.47 | $38.38 | $39.38 | 0 |
| Oct 6, 2025 – Oct 10, 2025 | $39.74 | $40.23 | $34.94 | $34.94 | 0 |
| Oct 13, 2025 – Oct 17, 2025 | $36.33 | $37.50 | $33.80 | $35.44 | 0 |
| Oct 20, 2025 – Oct 24, 2025 | $35.75 | $35.86 | $33.12 | $35.46 | 0 |
| Oct 27, 2025 – Oct 31, 2025 | $35.02 | $35.07 | $32.68 | $33.42 | 0 |
| Nov 3, 2025 – Nov 7, 2025 | $34.20 | $34.50 | $31.01 | $31.73 | 0 |
| Nov 10, 2025 – Nov 14, 2025 | $32.01 | $34.50 | $30.93 | $34.30 | 0 |
| Nov 17, 2025 – Nov 21, 2025 | $32.71 | $32.71 | $28.70 | $30.64 | 0 |
| Nov 24, 2025 – Nov 28, 2025 | $31.05 | $32.50 | $31.01 | $32.50 | 0 |
| Dec 1, 2025 – Dec 5, 2025 | $32.50 | $33.09 | $30.00 | $32.88 | 0 |
| Dec 8, 2025 – Dec 12, 2025 | $32.00 | $32.03 | $28.50 | $30.35 | 0 |
| Dec 15, 2025 – Dec 19, 2025 | $29.40 | $29.50 | $27.50 | $29.31 | 0 |
| Dec 22, 2025 – Dec 26, 2025 | $28.88 | $28.88 | $25.83 | $27.68 | 0 |
| Dec 29, 2025 – Jan 2, 2026 | $26.19 | $26.89 | $25.80 | $26.37 | 0 |
| Jan 5, 2026 – Jan 9, 2026 | $26.70 | $28.81 | $26.00 | $28.78 | 0 |
| Jan 12, 2026 – Jan 16, 2026 | $28.49 | $28.49 | $26.80 | $27.05 | 0 |
| Jan 19, 2026 – Jan 23, 2026 | $26.69 | $27.00 | $25.52 | $26.48 | 0 |
| Jan 26, 2026 – Jan 30, 2026 | $25.57 | $26.30 | $24.18 | $24.18 | 0 |
| Feb 2, 2026 – Feb 6, 2026 | $23.50 | $24.53 | $23.17 | $24.52 | 0 |
| Feb 9, 2026 – Feb 13, 2026 | $24.37 | $24.69 | $23.20 | $23.82 | 0 |
| Feb 16, 2026 – Feb 20, 2026 | $23.14 | $25.00 | $23.14 | $24.93 | 0 |
| Feb 23, 2026 – Feb 27, 2026 | $25.29 | $25.47 | $24.10 | $24.10 | 0 |
| Mar 2, 2026 – Mar 6, 2026 | $23.28 | $24.40 | $21.20 | $23.14 | 0 |
| Mar 9, 2026 – Mar 13, 2026 | $22.50 | $24.64 | $21.99 | $24.43 | 0 |
| Mar 16, 2026 – Mar 20, 2026 | $24.33 | $25.00 | $19.11 | $19.11 | 0 |
| Mar 23, 2026 – Mar 27, 2026 | $21.36 | $23.14 | $21.16 | $23.04 | 0 |
| Mar 30, 2026 – Apr 2, 2026 | $23.15 | $27.33 | $23.15 | $27.32 | 0 |
| Apr 6, 2026 – Apr 10, 2026 | $27.24 | $28.06 | $24.81 | $25.33 | 0 |
| Apr 13, 2026 – Apr 17, 2026 | $26.36 | $27.40 | $25.45 | $27.40 | 0 |
| Apr 20, 2026 – Apr 24, 2026 | $26.39 | $26.72 | $22.34 | $23.95 | 0 |
| Apr 27, 2026 – May 1, 2026 | $23.50 | $23.50 | $22.20 | $23.34 | 0 |
| May 4, 2026 – May 8, 2026 | $22.05 | $22.48 | $21.32 | $21.50 | 0 |
| May 11, 2026 – May 15, 2026 | $21.43 | $22.00 | $19.11 | $19.50 | 0 |
| May 18, 2026 – May 22, 2026 | $19.21 | $22.58 | $18.56 | $21.01 | 0 |
| May 25, 2026 – May 29, 2026 | $20.11 | $20.90 | $19.08 | $20.01 | 0 |
| Jun 1, 2026 – Jun 5, 2026 | $19.10 | $19.63 | $17.10 | $17.20 | 0 |
| Jun 8, 2026 – Jun 12, 2026 | $16.95 | $18.00 | $16.92 | $17.60 | 0 |
| Jun 15, 2026 – Jun 18, 2026 | $17.97 | $18.17 | $17.00 | $17.12 | 0 |
| Jun 22, 2026 – Jun 26, 2026 | $17.27 | $18.06 | $16.36 | $16.77 | 0 |
| Jun 29, 2026 – Jul 2, 2026 | $17.15 | $18.50 | $17.15 | $18.50 | 0 |
| Jul 6, 2026 – Jul 10, 2026 | $18.57 | $19.97 | $17.80 | $19.97 | 0 |
| Jul 13, 2026 – Jul 17, 2026 | $19.19 | $20.40 | $18.54 | $18.74 | 0 |
| Jul 20, 2026 – Jul 24, 2026 | $18.37 | $19.40 | $17.97 | $18.29 | 0 |
| Jul 27, 2026 – Jul 31, 2026 | $18.32 | $19.00 | $17.24 | $17.43 | 0 |
| Aug 3, 2026 – Aug 7, 2026 | $17.55 | $18.99 | $16.57 | $18.99 | 0 |
| Aug 10, 2026 – Aug 14, 2026 | $18.68 | $19.19 | $18.57 | $19.00 | 0 |
| Aug 17, 2026 – Aug 21, 2026 | $18.30 | $19.00 | $16.80 | $17.00 | 0 |
| Aug 24, 2026 – Aug 28, 2026 | $16.83 | $18.73 | $16.70 | $18.28 | 0 |
| Aug 31, 2026 – Sep 4, 2026 | $17.78 | $17.78 | $16.23 | $17.61 | 0 |
Valuation
| Metric | Value | Upside |
|---|---|---|
| IC Value | $51.45 | +192% |
| P/E | -11.86 | |
| P/B | 11.06 | |
| P/S | 26.24 | |
| EV/EBITDA | -12.93 | |
| PEG | -7.75 | |
| P/TBV | 11.87 |
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | IC | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | $19.93 | $6.05 | |||
| 2025 | $24.43 | $4.88 |
Historic valuation ratios
Pick a category, then toggle metrics to compare.
Line items
Line items
Line items
About Ascentage Pharma Group International
Based in Suzhou, China, Ascentage Pharma Group International is a biotechnology firm primarily focused on clinical-stage development. The company is dedicated to discovering and advancing therapeutic solutions for a range of medical conditions, including various cancers, chronic hepatitis B virus (HBV) infections, and age-related ailments. A cornerstone of its product pipeline is HQP1351, a BCR-ABL inhibitor specifically designed to address BCR-ABL1 mutants, notably those carrying the T315I mutation. The company's portfolio also encompasses APG-2575, an orally administered, selective Bcl-2 inhibitor aimed at treating hematologic malignancies and solid tumors. Another key asset, APG-115, is an oral small molecule that intervenes in MDM2-p53 protein-protein interactions, showing potential for both solid and blood cancers. Further bolstering its oncology efforts is APG-1252, a small molecule therapy engineered to reactivate programmed cell death (apoptosis) by dually inhibiting Bcl-2 and Bcl-xL proteins, targeting diseases such as small-cell lung cancer, non-small cell lung cancer, neuroendocrine tumors, and non-Hodgkin's lymphoma. Beyond these, Ascentage is actively developing APG-1387, a small molecule apoptosis inhibitor designated for advanced solid tumors and chronic HBV. Its pipeline also features APG-2449, an oral inhibitor of FAK, ROS1, and ALK kinases; APG-5918, a selective, orally available embryonic ectoderm development inhibitor; APG-265, an MDM2 protein degrader; and UBX1967/1325, which are additional Bcl-2 inhibitors. In addition to its core pharmaceutical activities, the company engages in medical research, clinical trial operations, venture capital investments, and offers rental and technology promotion services. Ascentage Pharma also cultivates strategic partnerships with various biotechnology and pharmaceutical companies, alongside research institutions. The company was founded in 2009.
- CEO
- Dajun Yang
- Employees
- 767
- Beta
- 0.66
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | IC Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | Value | Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| AAPG | Ascentage Pharma Group In… | $18.99 | 1.57B | $4.89 | -74% | -11.86 | 11.06 | 26.24 | -12.93 | -7.75 | 11.87 | 76.41% | -211.14% | -216.47% | -155.53% | -154.06% | -37.55% | 1.49 | -22.42 | 1.79 | 1.66 | 0.45 | 152.99% | -43.05% | 785.91% | -8.20% | -0.71 | -157.01% | 0.00% | 0.00% | 6.36% | -12.01 | -11.79 | 25.36 | 2.90 |
| APGE | Apogee Therapeutics, Inc. | $134.23 | 8.31B | — | — | -17.06 | 4.83 | — | -14.33 | -61.18 | 4.83 | 0.00% | 0.00% | 0.00% | -31.57% | -146.27% | -30.26% | 0.01 | — | 26.57 | 26.38 | 0.48 | 27.88% | — | 34.97% | -5.33% | -8.15 | -119.12% | 0.00% | 0.00% | 0.00% | -12.75 | -15.66 | — | 77.81 |
| CELC | Celcuity Inc. | $92.92 | 4.53B | — | — | -33.90 | 59.68 | — | -36.03 | -100.98 | 59.68 | 0.00% | 0.00% | 0.00% | -163.80% | 206.10% | -49.75% | 1.94 | -10.04 | 10.55 | 10.00 | -0.19 | 33.57% | — | 83.39% | -2.56% | -3.47 | 183.76% | 0.00% | 0.00% | 0.76% | -33.42 | -37.48 | — | 8.36 |
| CGON | CG Oncology Inc. | $72.42 | 6.39B | $32.48 | -55% | -30.87 | 6.60 | 1230.16 | -26.54 | -64.96 | 6.70 | -15.02% | -4722.13% | -3985.02% | -21.67% | -4199.76% | -20.82% | 0.01 | — | 24.63 | 24.09 | 0.16 | 47.52% | 254.70% | 67.81% | -2.67% | -4.29 | -2916.46% | 0.00% | 0.00% | 0.00% | -22.20 | -31.96 | 1048.19 | 76.12 |
| IRON | Disc Medicine, Inc. | $78.91 | 3.03B | — | — | -9.99 | 2.86 | — | -6.40 | -19.29 | 2.86 | 0.00% | 0.00% | 0.00% | -35.86% | 717.87% | -32.55% | 0.00 | -65.43 | 21.94 | 21.59 | 0.43 | 51.77% | — | 92.02% | -8.56% | -4.92 | 551.51% | 0.00% | 0.00% | 0.00% | -5.63 | -7.33 | — | 18.25 |
| LEGN | Legend Biotech Corporatio… | $19.05 | 3.52B | $28.57 | +50% | -11.61 | 3.45 | 3.36 | -12.57 | -17.88 | 3.73 | 60.34% | -13.27% | -28.85% | -29.14% | -37.11% | -17.49% | 0.41 | -6.38 | 1.96 | 1.88 | 2.10 | 64.95% | 64.04% | 6.26% | -4.86% | -0.16 | -45.68% | 0.00% | 0.00% | 15.97% | -21.40 | -17.38 | 2.84 | 2.01 |
| RARE | Ultragenyx Pharmaceutical… | $24.93 | 2.46B | $9.58 | -62% | -3.66 | -26.30 | 3.13 | -5.67 | — | -7.01 | 83.80% | -79.49% | -85.44% | -656.03% | -567.31% | -37.89% | -15.95 | -8.63 | 2.48 | 2.22 | -1.78 | -7.31% | 20.13% | 11.93% | -22.43% | -1.21 | -500.50% | 0.00% | 0.00% | 0.00% | -5.02 | -5.69 | 3.99 | -3.62 |
| XENE | Xenon Pharmaceuticals Inc… | $64.30 | 6.22B | $18.29 | -72% | -12.65 | 7.52 | 583.62 | -11.21 | -28.21 | 7.52 | 66.09% | -4974.27% | -4612.13% | -51.76% | -419.58% | -38.87% | 0.01 | — | 13.42 | 13.17 | 0.56 | 44.85% | — | 51.75% | -6.39% | -6.68 | -314.81% | 0.00% | 0.00% | 1.31% | -10.28 | -13.70 | 511.50 | 4.18 |
| ZLAB | Zai Lab Limited | $18.37 | 2.07B | $14.42 | -22% | -11.46 | 2.81 | 4.37 | -9.77 | — | 3.15 | 58.47% | -48.59% | -38.15% | -22.56% | -94.61% | -14.89% | 0.31 | -42.92 | 2.45 | 1.91 | 2.88 | -38.46% | 15.33% | -42.51% | -7.90% | -0.36 | -68.36% | 0.00% | 0.00% | 7.91% | -6.92 | -9.73 | 3.36 | -0.12 |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($51.45 ÷ $17.61) − 1 = +192.16% (IC, example).